Fluoride inhibition of enolase: crystal structure and thermodynamics.
Journal: 2006/April - Biochemistry
ISSN: 0006-2960
Abstract:
Enolase is a dimeric metal-activated metalloenzyme which uses two magnesium ions per subunit: the strongly bound conformational ion and the catalytic ion that binds to the enzyme-substrate complex inducing catalysis. The crystal structure of the human neuronal enolase-Mg2F2P(i) complex (enolase fluoride/phosphate inhibitory complex, EFPIC) determined at 1.36 A resolution shows that the combination of anions effectively mimics an intermediate state in catalysis. The phosphate ion binds in the same site as the phosphate group of the substrate/product, 2-phospho-D-glycerate/phosphoenolpyruvate, and induces binding of the catalytic Mg2+ ion. One fluoride ion bridges the structural and catalytic magnesium ions while the other interacts with the structural magnesium ion and the ammonio groups of Lys 342 and Lys 393. These fluoride ion positions correspond closely to the positions of the oxygen atoms of the substrate's carboxylate moiety. To relate structural changes resulting from fluoride, phosphate, and magnesium ions binding to those that are induced by phosphate and magnesium ions alone, we also determined the structure of the human neuronal enolase-Mg2P(i) complex (enolase phosphate inhibitory complex, EPIC) at 1.92 A resolution. It shows the closed conformation in one subunit and a mixture of open and semiclosed conformations in the other. The EPFIC dimer is essentially symmetric while the EPIC dimer is asymmetric. Isothermal titration calorimetry data confirmed binding of four fluoride ions per dimer and yielded Kb values of 7.5 x 10(5) +/- 1.3 x 10(5), 1.2 x 10(5) +/- 0.2 x 10(5), 8.6 x 10(4) +/- 1.6 x 10(4), and 1.6 x 10(4) +/- 0.7 x 10(4) M(-1). The different binding constants indicate negative cooperativity between the subunits; the asymmetry of EPIC supports such an interpretation.
Relations:
Content
Citations
(16)
References
(21)
Chemicals
(1)
Genes
(1)
Organisms
(2)
Processes
(5)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Biochemistry 45(3): 793-800

Fluoride Inhibition of Enolase: Crystal Structure and Thermodynamics<sup><a href="#FN1" rid="FN1" class=" fn">↕</a></sup><sup><a href="#FN2" rid="FN2" class=" fn">†</a></sup>

Department of Chemistry &amp; Biochemistry, University of South Carolina, Columbia, SC 29208
Center for Colon Cancer Research, University of South Carolina, Columbia, SC 29208
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602
corresponding author, Lukasz Lebioda, Department of Chemistry &amp; Biochemistry, University of South Carolina, Columbia, SC 29208, Phone (803) 777-2140, Fax (803) 777-9521, E-mail: ude.cs.mehc.liam@adoibel

Abstract

Enolase is a dimeric metal-activated metalloenzyme, which uses two magnesium ions per subunit: the strongly bound conformational ion and the catalytic ion that binds to the enzyme-substrate complex inducing catalysis. The crystal structure of the human neuronal enolase-Mg2F2Pi complex (enolase fluoride/phosphate inhibitory complex, EFPIC) determined at 1.36 Å resolution shows that the combination of anions effectively mimics an intermediate state in catalysis. The phosphate ion binds in the same site as the phosphate group of the substrate/product, 2-phospho-D-glycerate/phosphoenolpyruvate, and induces binding of catalytic Mg ion. One fluoride ion bridges the structural and catalytic magnesium ions while the other interacts with the structural magnesium ion and the ammonio groups of Lys 342 and Lys 393. These fluoride ion positions correspond closely to the positions of the oxygen atoms of the substrate's carboxylate moiety. To relate structural changes resulting from fluoride, phosphate and magnesium ions binding to those that are induced by phosphate and magnesium ions alone, we also determined the structure of the human neuronal enolase-Mg2Pi complex (enolase phosphate inhibitory complex, EPIC) at 1.92 Å resolution. It shows the closed conformation in one subunit and a mixture of open and semi-closed conformations in the other. The EPFIC dimer is essentially symmetric while EPIC dimer is asymmetric. Isothermal titration calorimetry data confirmed binding of four fluoride ions per dimer and yielded Kb values of 7.5 × 10 ± 1.3 × 10, 1.2 × 10 ± 0.2 × 10, 8.6 × 10 ± 1.6 × 10, 1.6 × 10 ± 0.7 × 10 M. The different binding constants indicate negative cooperativity between the subunits; the asymmetry of EPIC supports such an interpretation.

Keywords: enolase, fluoride inhibition, negative cooperativity, glycolysis, crystal structure, isothermal titration calorimetry
Abstract

It has long been known that fluoride ions inhibit alcoholic fermentation and glycolysis. Warburg and Christian have shown that this is due to the inhibition of enolase (1). Enolase (2-phospho-D-glycerate hydrolyase, EC.4.2.1.11) is an enzyme functioning in the Embden-Meyerhof-Parnas glycolytic pathway that catalyzes the reversible dehydration of 2-phospho-D-glycerate (PGA1) to yield PEP1. The enzyme molecule is composed of two identical subunits (2) and has a requirement for two divalent cations per active site for catalytic activity. The first one is often referred to as the “conformational” ion because its binding induces a conformational change. The second ion binds only in the presence of a substrate (or its analogues) and is necessary for enzymatic activity. We refer to it as the “catalytic” ion. These cations are Mg under physiological conditions but can be replaced by a variety of metal ions (3).

The enolase subunit has been found to exist in three major conformational states. The closed conformation has been observed in the catalytic complex with PGA (4, 5) and with strong inhibitors such as phosphonoacetohydroxamate (6). The semi-closed conformation has been found in the catalytic complex with PEP (4); it differs from the closed conformation in the position of the loop containing His 157, which does not form a direct hydrogen bond with the phosphate moiety but interacts via a water molecule. The open conformation is observed in the absence of substrates or their inhibitory analogues (7).

In addition to its significance for the brewing industry, the fluoride inhibition of enolase has practical ramifications in the treatment of dental plaque in which deep layers are highly anaerobic and dependent on glycolysis for energy requirements and, even more importantly, on the presence of PEP for the transport of sugar by the PEP-dependent phospho-transferase system (8).

From the very beginning, it was suggested that the inhibition of enolase is due to the formation of a magnesium•fluoride•phosphate complex (1). Later, it was found that rabbit muscle enolase was only weakly affected by F alone and that in the presence of Pi the inhibition was strong and competitive with respect to the substrate (9). These findings were confirmed by studies (10) that showed cooperativity of Pi and F binding and, more specifically, that F is coordinated to the enzyme bound Mg.

A more detailed study of fluoride binding by yeast enolase was carried out with a fluoride ion-specific electrode by Bunick and Kashket (11). They presented evidence for a binding mechanism in which one F ion was bound per subunit containing conformational Mg ion and Pi. An additional F could bind only after additional, presumably catalytic, Mg ion bound. The reported dissociation constants for these fluoride ions were 5.0 × 10 and 8.2 × 10, respectively. Addition of the substrate, PGA, led to the release of both bound F ions in a competitive fashion. However, subsequent studies showed that in the presence of PGA, yeast enolase is inhibited by F, though in a complicated, time-dependent fashion (12), becoming non-competitive over time (cf. reference 10).

There is a large variation in the strength of F inhibition in the presence of different activating cations (10, 13). The Mg activated yeast enzyme is most strongly inhibited; the Mn activated enzyme is inhibited 40 times more weakly; and the Zn activated enzyme shows no inhibition by F. Mn ion is, however, paramagnetic and enabled utilization of techniques that are not applicable to Mg complexes (13, 14). These studies quantitatively demonstrated strong positive cooperativity in F and Pi binding with a 10-fold increase in Kd for F dissociation from the ternary complex yeast enolase-Mn-F and a 10-fold increase in Kd for Pi dissociation from the enolase•Mn•Pi complex when compared to the quaternary complex. The data also indicated that one F binds in the active site displacing a water molecule from the first coordination sphere of the bound Mn ion. To explain the potency of the inhibition, Nowak and Maurer suggested that the quaternary complex formation induces a transition state-like conformation of the enzyme (14).

Zhang et al. reported crystallographic studies of the yeast enolase•fluoride•phosphate complex (15). However, these studies were carried out at a high ammonium sulfate (ca 2 M) concentration, which prohibited binding of the catalytic magnesium ion and presumably the second fluoride ion. Here we report a higher resolution study of the structure of human neuron specific enolase in the presence of fluoride, phosphate and magnesium ions at lower (ca 0.4 M) ionic strength.

Most of the previous studies were carried out using yeast enolase 1 while here investigations of hNSE are reported to take advantage of the superior scattering power of its crystals. It is likely however, that the results are applicable also to the yeast enzyme and vice versa since enolase, like all glycolytic enzymes, is strongly conserved. Yeast enolase 1 and NSE are 62% identical, (73% similar) with two small (two and one residue) deletions present in all known mammalian enolases. All active site residues are conserved (16) and the kinetic parameters are similar (J. M. Brewer and R. Kendrick, unpublished observations).

Inspection of the active site revealed a number of features that are in excellent agreement with previously published solution binding studies (1, 9-14). The structures reported here likely represent the inhibitory complexes formed at physiological conditions. The fluoride/phosphate binding is confirmed by our isothermal titration calorimetry (ITC) study, which is to our knowledge the first thermodynamic documentation of cooperativity between enolase subunits.

Footnotes

Atomic coordinates have been deposited with the Protein Data Bank as entries 2AKZ and 2AKM for the structure of fluoride/phosphate complex and the phosphate complex respectively.

This work was supported in part by NIH grant CA076560. Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at www.ser-cat.org/members.html. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.

Abbreviations: PGA – 2-phospho-D-glycerate; PEP – phosphoenolpyruvate; hNSE – human neuron specific enolase; EFPIC – enolase fluoride/phosphate inhibitory complex, (hNSE•Mg2•F2•Pi)2; EPIC – enolase phosphate inhibitory complex; PDB – Protein Data Bank

Footnotes

REFERENCES

REFERENCES

References

  • 1. Warburg O, Christian WIsolierung und Kristallisation des Garungsferments Enolase. Biochem. Z. 1941;310:384–421.[PubMed][Google Scholar]
  • 2. Brewer JM, Weber GThe reversible dissociation of yeast enolase. Proc. Natl. Acad. Sci. USA. 1968;59:2l6–223.[PubMed][Google Scholar]
  • 3. Brewer JMYeast enolase: mechanism of activation by metal ions. CRC Crit. Rev. Biochem. 1981;11:209–254.[PubMed][Google Scholar]
  • 4. Larsen TM, Wedekind JE, Rayment I, Reed GHA carboxylate oxygen of the substrate bridges the magnesium ions at the active site of enolase: structure of the yeast enzyme complexed with the equilibrium mixture of 2-phosphoglycerate and phosphoenolpyruvate at 1.8 A resolution. Biochemistry. 1996;35:4349–58.[PubMed][Google Scholar]
  • 5. Zhang E, Brewer JM, Minor W, Carreira LA, Lebioda LMechanism of enolase: the crystal structure of asymmetric dimer enolase- 2-phospho-D-glycerate/enolase-phosphoenolpyruvate at 2.0 Å resolution. Biochemistry. 1997;36:12526–12534.[PubMed][Google Scholar]
  • 6. Wedekind JE, Poyner RR, Reed GH, Rayment IChelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-A resolution. Biochemistry. 1994;33:9333–9342.[PubMed][Google Scholar]
  • 7. Lebioda L, Stec B, Brewer JM. The Structure of Yeast Enolase at 2.25 Å Resolution. An Eightfold βα Barrel with a Novel ββαα(βα)6 Topology. J. Biol. Chem. 1989;264:3685–3693.[PubMed]
  • 8. Hata S, Iwami Y, Kamiyama K, Yamada TBiochemical mechanisms of enhanced inhibition of fluoride on the anaerobic sugar metabolism by Streptococcus sanguis. J. Dent. Res. 1990;69:1244–1247.[PubMed][Google Scholar]
  • 9. Cimasoni GInhibition of enolase by fluoride in vitro. Caries Res. 1972;6:93–102.[PubMed][Google Scholar]
  • 10. Wang T, Himoe AKinetics of the rabbit muscle enolase-catalyzed dehydration of 2-phosphoglycerate. J. Biol. Chem. 1974;249:3895–3902.[PubMed][Google Scholar]
  • 11. Bunick FJ, Kashket SBinding of fluoride by yeast enolase. Biochemistry. 1982;21:4285–4290.[PubMed][Google Scholar]
  • 12. Spencer SG, Brewer JMSubstrate-dependent inhibition of yeast enolase by fluoride. Biochem. Biophys. Res. Com. 1982;106:553–558.[PubMed][Google Scholar]
  • 13. Maurer PJ, Nowak T. Fluoride inhibition of yeast enolase. 1. Formation of the ligand complexes. Biochemistry. 1981;20:6894–6900.[PubMed]
  • 14. Nowak T, Maurer PJ. Fluoride inhibition of yeast enolase. 2. Structural and kinetic properties of the ligand complexes determined by nuclear relaxation rate studies. Biochemistry. 1981;20:6901–6911.[PubMed]
  • 15. Lebioda L, Zhang E, Lewinski K, Brewer JMFluoride inhibition of yeast enolase: crystal structure of the enolase-Mg-F-Pi complex at 2.6 Å resolution. Proteins. 1993;20:219–225.[PubMed][Google Scholar]
  • 16. Brewer JM, Lebioda LCurrent Perspectives on the Mechanism of Catalysis by the Enzyme Enolase. Advan. Biophys. Chem. 1997;6:111–141.[PubMed][Google Scholar]
  • 17. Chai G, Brewer JM, Lovelace LL, Aoki T, Minor W, Lebioda LExpression, purification and the 1.8 Å resolution crystal structure of human neuron specific enolase. J. Mol. Biol. 2004;341:1015–1021.[PubMed][Google Scholar]
  • 18. Otwinowski Z, Minor WProcessing of X-ray diffraction data collected in oscillation mode. Methods Enzym. 1997;276:307–326.[PubMed][Google Scholar]
  • 19. Russel A, Cambillau C “Turbo Frodo” Silicon Graphics Geometry Partners Directory. Silicon Graphics; Mountain View Ca.: 1991. p. 86. [PubMed][Google Scholar]
  • 20. Brunger AT, Adams PD, Clore GM, Delano WL, Gros P, Grosse-Kunstleve, Reed RJ, Jiang J, Kuszewskic J, Nilges M, Pannu N, Read RJ, Rice LM, Simonson T, Warren GLCrystallography and NMR System: A new software suite for macromolecular structure determination. Acta Crystallogr. 1998;D54:905–921.[PubMed][Google Scholar]
  • 21. Sheldrick G. 1997.
  • 22. Laskowski RA, MacArthur MW, Moss DS, Thornton JMPROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 1993;26:283–291.[PubMed][Google Scholar]
  • 23. CCP4 The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. 1994;D50:760–763.[PubMed]
  • 24. Kraulis PJMOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 1991;24:946–950.[PubMed][Google Scholar]
  • 25. Merritt EA, Bacon DJRaster3D: photorealistic molecular graphics. Methods Enzymol. 1997;277:505–524.[PubMed][Google Scholar]
  • 26. Rocchia W, Alexov E, Honig BExtending the applicability of the nonlinear Poisson-Boltzmann equation: Multiple dielectric constants and multivalent ions. J. Phys. Chem. B. 2001;105:6507–6514.[PubMed][Google Scholar]
  • 27. Marangos PJ, Schmechel DENeuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann. Rev. Neurosci. 1987;10:269–295.[PubMed][Google Scholar]
  • 28. Brewer JMThe interaction of potassium chloride and acetate with yeast enolase. Arch. Biochem. Biophys. 1969;134:59–66.[PubMed][Google Scholar]
  • 29. International Tables for X-ray Crystallography. 1974;4:73.[PubMed]
  • 30. Dister A, Lohse DL, Sevov SCChains, planes, and tunnels of metal diphosphonates: synthesis, structure, and characterization of Na3Co(O3PCH2PO3)(OH), Na3Mg(O3PCH2PO3)F.H2O, Na2Co(O3PCH2PO3).H2O, Na2Co(O3PCH2CH2CH2PO3)(OH), and Co2(O3PCH2PO3)(H2O) J. Chem. Soc., Dalton Trans. 1999;1999:1805–1812.[PubMed][Google Scholar]
  • 31. Brewer JM, Glover CVC, Holland MJ, Lebioda LEnzymatic function of loop movement in enolase: Preparation and some properties of H159N, H159A, H159F and N207A enolases. J. Prot. Chem. 2003;22:353–361.[PubMed][Google Scholar]
  • 32. Holleman WHThe use of absorption optics to measure dissociation of yeast enolase into enzymatically active monomers. Biochim. Biophys. Acta. 1973;327:176–185.[PubMed][Google Scholar]
  • 33. Wold F. Enolase. In: Boyer PD, editor. The Enzymes. 3-rd edition Vol. 5. Academic Press; New York: 1971. pp. 499–538. [PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.